Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.
BofA Securities maintains Buy on Chevron with $183 target, citing strong free cash flow, Hess synergies, structural cost ...
Chevron projects 10%+ EPS growth, higher free cash flow, and strategic oil and gas expansion. The company targets 2–3% annual oil and gas production growth and $70 Brent breakeven.
Chevron (NYSE: CVX) used its investor day in New York to signal a confident long-term outlook, unveiling a five-year plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback